Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study

Respiratory Medicine

Volumn 104, Issue 5, 2010, Pages 717-723

  Schutt, Amanda C ^a   Bullington, Wendy M ^a   Judson, Marc A ^b  

^a MUSC Medical Center   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Corticosteroids; Sarcoidosis; Therapy

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CHLOROQUINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; THALIDOMIDE;

ARTICLE; CLINICAL RESEARCH; CONSENSUS; CORTICOSTEROID THERAPY; DELPHI STUDY; DISEASE SEVERITY; DRUG CHOICE; DRUG DOSE REDUCTION; HUMAN; MAXIMUM PERMISSIBLE DOSE; PRIORITY JOURNAL; QUESTIONNAIRE; RECOMMENDED DRUG DOSE; SARCOIDOSIS; CLINICAL PRACTICE; DRUG ADMINISTRATION; FEMALE; MALE; SARCOIDOSIS, PULMONARY;

ADRENAL CORTEX HORMONES; CONSENSUS; DELPHI TECHNIQUE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SARCOIDOSIS, PULMONARY;

EID: 77951623623     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.12.009     Document Type: Article

References (17)

1. Sartwell P.E., and Edwards L.B. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 99 (1974) 250-257
2. Hunninghake G.W., Gilbert S., Peuringer R., et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 149 (1994) 893-898
3. Judson M.A. Sarcoidosis: clinical presentation, diagnosis, and treatment. Am J Med Sci 335 (2008) 26-33
4. Judson M.A. An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. Chest 115 (1999) 1158-1165
5. Paramothayan S., and Jones P.W. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 287 (2002) 1301-1307
6. Gibson G.J., Prescott R.J., Muers M.F., et al. British Thoracic Society Sarcoidosis Study: effects of long term corticosteroid treatment. Thorax 51 (1996) 238-247
7. Jindal S.K. Practical issues and challenges in the diagnosis and treatment of pulmonary sarcoidosis. Drugs 67 (2007) 17-26
8. Baughman R.P. Costabel U, du Bois RM. Treatment of sarcoidosis. Clin Chest Med 29 (2008) 533-548
9. Paramothayan S., and Lasserson T. Treatments for pulmonary sarcoidosis. Respir Med 102 (2008) 1-9
10. de Meyrick J. The Delphi method and health research. Health Educ 103 (2003) 7-16
11. Hasson F., Keeney S., and McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 32 (2000) 1008-1015
12. Hunninghake G.W., Costabel U., Ando M., et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 (1999) 149-173
13. Romer F.K. Presentation of sarcoidosis and outcome of pulmonary changes. Dan Med Bull 29 (1982) 27-32
14. Israel H.L., Fouts D.W., and Beggs R.A. A controlled trial of prednisone treatment of sarcoidosis. Am Rev Respir Dis 107 (1973) 609-614
15. Zaki M.H., Lyons H.A., Leilop L., et al. Corticosteroid therapy in sarcoidosis. NY State J Med 87 (1987) 496-499
16. Eule H., Weinnecke A., and Roth I. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Ann NY Acad Sci 465 (1986) 695-701
17. Winterbauer R.H., Kirtland S.H., and Corley D.E. Treatment with corticosteroids. Clin Chest Med 18 (1997) 843-851